{"id":1988,"date":"2018-06-19T12:29:12","date_gmt":"2018-06-19T17:29:12","guid":{"rendered":"https:\/\/restruct-lgmd-2021.pantheonsite.io\/?p=1988"},"modified":"2018-06-19T12:29:12","modified_gmt":"2018-06-19T17:29:12","slug":"lgmd-researcher-chamberlain","status":"publish","type":"post","link":"https:\/\/www.lgmd-info.org\/fr\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/","title":{"rendered":"Chercheur du LGMD : Jeffrey S. Chamberlain, Ph.D."},"content":{"rendered":"<p><strong>\"LA RECHERCHE SOUS LES PROJECTEURS DE LA LGMD\"<\/strong><\/p>\n<p><strong>Chercheur du LGMD :<\/strong> Jeffrey S. Chamberlain, Ph.D.<a href=\"https:\/\/www.lgmd-info.org\/wp-content\/uploads\/2018\/06\/Chamberlain-Jeff.png\"><img decoding=\"async\" class=\"lazyload size-medium wp-image-1987 alignright\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27300%27%20height%3D%27225%27%20viewBox%3D%270%200%20300%20225%27%3E%3Crect%20width%3D%27300%27%20height%3D%27225%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.lgmd-info.org\/wp-content\/uploads\/2018\/06\/Chamberlain-Jeff-300x225.png\" alt=\"\" width=\"300\" height=\"225\" \/><\/a><\/p>\n<p><strong>Affiliation :<\/strong>\u00a0 \u00c9cole de m\u00e9decine de l'Universit\u00e9 de Washington<\/p>\n<p><strong>R\u00f4le ou position<\/strong>:  Professeur, Chaire McCaw sur les dystrophies musculaires, Directeur du Centre de recherche Wellstone sur les dystrophies musculaires - Seattle<\/p>\n<p><strong>Quels sont les \u00e9tudes et la formation qui vous ont permis d'acc\u00e9der \u00e0 votre poste actuel ?<\/strong><\/p>\n<p>J'ai obtenu une licence et un doctorat en biochimie, puis j'ai suivi une formation post-doctorale en g\u00e9n\u00e9tique mol\u00e9culaire.<\/p>\n<p><strong>Qu'est-ce qui vous a amen\u00e9 \u00e0 suivre une carri\u00e8re dans la recherche et \u00e0 \u00e9tudier la dystrophie musculaire en particulier ?<\/strong><\/p>\n<p>Pendant que je pr\u00e9parais mon doctorat, je me suis int\u00e9ress\u00e9e au d\u00e9veloppement musculaire et j'ai commenc\u00e9 \u00e0 me renseigner sur les maladies musculaires.  J'ai suivi une formation post-doctorale sur la dystrophie musculaire de Duchenne et j'ai commenc\u00e9 \u00e0 m'int\u00e9resser et \u00e0 \u00eatre intrigu\u00e9e par le concept de th\u00e9rapie g\u00e9nique.  Lorsque j'ai cr\u00e9\u00e9 mon propre laboratoire, j'ai d\u00e9cid\u00e9 de me concentrer sur la th\u00e9rapie g\u00e9nique pour les dystrophies musculaires ainsi que sur l'\u00e9tude de la fonction des prot\u00e9ines d\u00e9fectueuses dans les diff\u00e9rentes dystrophies.<\/p>\n<p><strong>Quels sont les sujets que vous \u00e9tudiez ?<\/strong><\/p>\n<p>J'\u00e9tudie actuellement les m\u00e9thodes de th\u00e9rapie g\u00e9nique des troubles musculaires, y compris les vecteurs pour d\u00e9livrer les g\u00e8nes aux tissus musculaires, les cassettes de r\u00e9gulation g\u00e9nique pour activer et d\u00e9sactiver les g\u00e8nes dans diff\u00e9rents tissus, et le r\u00f4le du syst\u00e8me immunitaire dans les dystrophies et dans le contexte de la th\u00e9rapie g\u00e9nique.  J'\u00e9tudie \u00e9galement la fonction et les interactions de diff\u00e9rentes prot\u00e9ines qui contribuent \u00e0 la fonction et \u00e0 la maladie musculaires, telles que la dystrophine et la FKRP.<\/p>\n<p><strong>Comment vos travaux aideront-ils les patients ? Sont-ils plut\u00f4t de nature scientifique ou pourraient-ils devenir un traitement pour les LGMD ou les m\u00e9decins en g\u00e9n\u00e9ral ?<\/strong><\/p>\n<p>Notre travail est \u00e0 la fois scientifique et ax\u00e9 sur le traitement.  Nous pensons que la meilleure fa\u00e7on de d\u00e9velopper des traitements efficaces est d'avoir une compr\u00e9hension d\u00e9taill\u00e9e de la biologie de base des diff\u00e9rents troubles musculaires.  Nous utilisons cette recherche fondamentale pour guider le d\u00e9veloppement des g\u00e8nes et des vecteurs n\u00e9cessaires \u00e0 une th\u00e9rapie g\u00e9nique s\u00fbre et efficace.<\/p>\n<p><strong>Qu'aimeriez-vous que les patients et les autres personnes int\u00e9ress\u00e9es par la LGMD sachent \u00e0 propos de la recherche (vos propres projets et le domaine en g\u00e9n\u00e9ral) ?<\/strong><\/p>\n<p>La th\u00e9rapie g\u00e9nique est pass\u00e9e d'un concept futuriste \u00e0 une approche prometteuse du traitement des maladies h\u00e9r\u00e9ditaires.  Plusieurs th\u00e9rapies g\u00e9niques ont \u00e9t\u00e9 approuv\u00e9es pour un usage commercial et peuvent \u00eatre prescrites par les m\u00e9decins.  Je pense que les th\u00e9rapies g\u00e9niques constituent l'approche la plus prometteuse pour traiter la plupart des diff\u00e9rents types de dystrophie musculaire.  Il est \u00e9galement important de comprendre que les d\u00e9fis qui limitent le d\u00e9veloppement de la th\u00e9rapie g\u00e9nique pour de nombreuses dystrophies sont les m\u00eames pour les diff\u00e9rentes maladies, et que les progr\u00e8s r\u00e9alis\u00e9s dans l'une d'entre elles contribuent \u00e0 rapprocher les traitements de la clinique pour toutes les dystrophies.  Des essais de th\u00e9rapie g\u00e9nique sont en cours pour plusieurs dystrophies musculaires et de nombreux autres sont sur le point d'\u00eatre test\u00e9s.  Nous sommes \u00e0 l'aube d'une r\u00e9volution dans le d\u00e9veloppement et l'application de nouvelles th\u00e9rapies g\u00e9n\u00e9tiques et je pense que c'est une p\u00e9riode extraordinaire pour voir que ces nouvelles technologies commencent enfin \u00e0 aider les patients et leurs familles.<\/p>\n<p><strong>Qu'est-ce qui vous incite \u00e0 continuer \u00e0 travailler dans ce domaine ? <\/strong><\/p>\n<p>Je travaille sur la dystrophie musculaire depuis 30 ans et je vois enfin de nouvelles th\u00e9rapies appliqu\u00e9es et fonctionner en clinique.  C'est la p\u00e9riode la plus passionnante de ma carri\u00e8re et je suis ravi de pouvoir contribuer au d\u00e9veloppement de nouvelles approches pour traiter diff\u00e9rents types de troubles musculaires.<\/p>\n<p><strong>Comment les patients peuvent-ils vous encourager et vous aider dans votre travail ?<\/strong><\/p>\n<p>Le financement de la recherche scientifique est en baisse dans tout le pays et, dans de nombreux milieux, il semble qu'il y ait presque une guerre contre l'enseignement et l'exploration des id\u00e9es et des principes scientifiques.  La chose la plus importante que les patients et les membres de leur famille puissent faire est d'encourager les membres de leur gouvernement local et national \u00e0 soutenir la recherche scientifique dans les universit\u00e9s du pays.  Presque toutes les approches th\u00e9rapeutiques innovantes et nouvelles, telles que les th\u00e9rapies g\u00e9niques et cellulaires, sont d\u00e9velopp\u00e9es exclusivement dans les universit\u00e9s avant d'\u00eatre reprises par les soci\u00e9t\u00e9s de biotechnologie et les grandes soci\u00e9t\u00e9s pharmaceutiques.<\/p>\n<p>&nbsp;<\/p>\n<p>* Merci de LIQUER, COMMENTER et PARTAGER cet article pour aider \u00e0 sensibiliser le public \u00e0 la LGMD !<\/p>\n<p>* Pour en savoir plus sur la dystrophie musculaire des ceintures (LGMD) ou pour lire d'autres \"Spotlight Interviews\", veuillez consulter notre site web \u00e0 l'adresse suivante <a href=\"https:\/\/www.lgmd-info.org\/fr\/\">https:\/\/lgmd-info.org<\/a><\/p>\n<p>#CureLGMD<\/p>\n<p>#LgmdDay2018<\/p>","protected":false},"excerpt":{"rendered":"<p>&#8220;LGMD SPOTLIGHT ON RESEARCH&#8221; LGMD Researcher: Jeffrey S. Chamberlain, Ph.D. [&hellip;]<\/p>","protected":false},"author":1,"featured_media":1987,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[91,92],"tags":[],"class_list":["post-1988","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-researcher-interview","category-researcher"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>LGMD RESEARCHER: Jeffrey S. Chamberlain, Ph.D. - LGMD Awareness Foundation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/www.lgmd-info.org\/fr\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LGMD RESEARCHER: Jeffrey S. Chamberlain, Ph.D. - LGMD Awareness Foundation\" \/>\n<meta property=\"og:description\" content=\"&#8220;LGMD SPOTLIGHT ON RESEARCH&#8221; LGMD Researcher: Jeffrey S. Chamberlain, Ph.D. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/www.lgmd-info.org\/fr\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/\" \/>\n<meta property=\"og:site_name\" content=\"LGMD Awareness Foundation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LGMDawareness\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-06-19T17:29:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lgmd-info.org\/wp-content\/uploads\/2021\/06\/LGMD-Logo_1200X630.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"dooley\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@LgmdAwareness\" \/>\n<meta name=\"twitter:site\" content=\"@LgmdAwareness\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"dooley\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#article\",\"isPartOf\":{\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/\"},\"author\":{\"name\":\"dooley\",\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#\/schema\/person\/007755074875959ad5503c1c969678c7\"},\"headline\":\"LGMD RESEARCHER: Jeffrey S. Chamberlain, Ph.D.\",\"datePublished\":\"2018-06-19T17:29:12+00:00\",\"dateModified\":\"2018-06-19T17:29:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/\"},\"wordCount\":675,\"publisher\":{\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#organization\"},\"image\":{\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#primaryimage\"},\"thumbnailUrl\":\"\",\"articleSection\":[\"LGMD Researcher - Interviews\",\"RESEARCHER\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/\",\"url\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/\",\"name\":\"LGMD RESEARCHER: Jeffrey S. Chamberlain, Ph.D. - LGMD Awareness Foundation\",\"isPartOf\":{\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2018-06-19T17:29:12+00:00\",\"dateModified\":\"2018-06-19T17:29:12+00:00\",\"breadcrumb\":{\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.lgmd-info.org\/de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LGMD RESEARCHER: Jeffrey S. Chamberlain, Ph.D.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#website\",\"url\":\"https:\/\/www.lgmd-info.org\/de\/\",\"name\":\"LGMD Awareness Foundation\",\"description\":\"Information Hub for the LGMD community\",\"publisher\":{\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lgmd-info.org\/de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#organization\",\"name\":\"LGMD Awareness Foundation, Inc.\",\"url\":\"https:\/\/www.lgmd-info.org\/de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/lgmd-info.org\/wp-content\/uploads\/2021\/02\/LGMD_Logo.png\",\"contentUrl\":\"https:\/\/lgmd-info.org\/wp-content\/uploads\/2021\/02\/LGMD_Logo.png\",\"width\":208,\"height\":61,\"caption\":\"LGMD Awareness Foundation, Inc.\"},\"image\":{\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LGMDawareness\/\",\"https:\/\/x.com\/LgmdAwareness\",\"https:\/\/www.instagram.com\/lgmdawareness\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#\/schema\/person\/007755074875959ad5503c1c969678c7\",\"name\":\"dooley\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lgmd-info.org\/de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c87b3b784fd4c1975884b6c3eab282b5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c87b3b784fd4c1975884b6c3eab282b5?s=96&d=mm&r=g\",\"caption\":\"dooley\"},\"sameAs\":[\"https:\/\/live-lgmd-2021.pantheonsite.io\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LGMD RESEARCHER: Jeffrey S. Chamberlain, Ph.D. - LGMD Awareness Foundation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/www.lgmd-info.org\/fr\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/","og_locale":"fr_FR","og_type":"article","og_title":"LGMD RESEARCHER: Jeffrey S. Chamberlain, Ph.D. - LGMD Awareness Foundation","og_description":"&#8220;LGMD SPOTLIGHT ON RESEARCH&#8221; LGMD Researcher: Jeffrey S. Chamberlain, Ph.D. [&hellip;]","og_url":"http:\/\/www.lgmd-info.org\/fr\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/","og_site_name":"LGMD Awareness Foundation","article_publisher":"https:\/\/www.facebook.com\/LGMDawareness\/","article_published_time":"2018-06-19T17:29:12+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.lgmd-info.org\/wp-content\/uploads\/2021\/06\/LGMD-Logo_1200X630.png","type":"image\/png"}],"author":"dooley","twitter_card":"summary_large_image","twitter_creator":"@LgmdAwareness","twitter_site":"@LgmdAwareness","twitter_misc":{"Written by":"dooley","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#article","isPartOf":{"@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/"},"author":{"name":"dooley","@id":"https:\/\/www.lgmd-info.org\/de\/#\/schema\/person\/007755074875959ad5503c1c969678c7"},"headline":"LGMD RESEARCHER: Jeffrey S. Chamberlain, Ph.D.","datePublished":"2018-06-19T17:29:12+00:00","dateModified":"2018-06-19T17:29:12+00:00","mainEntityOfPage":{"@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/"},"wordCount":675,"publisher":{"@id":"https:\/\/www.lgmd-info.org\/de\/#organization"},"image":{"@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#primaryimage"},"thumbnailUrl":"","articleSection":["LGMD Researcher - Interviews","RESEARCHER"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/","url":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/","name":"LGMD RESEARCHER: Jeffrey S. Chamberlain, Ph.D. - LGMD Awareness Foundation","isPartOf":{"@id":"https:\/\/www.lgmd-info.org\/de\/#website"},"primaryImageOfPage":{"@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#primaryimage"},"image":{"@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#primaryimage"},"thumbnailUrl":"","datePublished":"2018-06-19T17:29:12+00:00","dateModified":"2018-06-19T17:29:12+00:00","breadcrumb":{"@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"http:\/\/www.lgmd-info.org\/researcher-interview\/2018\/06\/19\/lgmd-researcher-chamberlain\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lgmd-info.org\/de\/"},{"@type":"ListItem","position":2,"name":"LGMD RESEARCHER: Jeffrey S. Chamberlain, Ph.D."}]},{"@type":"WebSite","@id":"https:\/\/www.lgmd-info.org\/de\/#website","url":"https:\/\/www.lgmd-info.org\/de\/","name":"LGMD Awareness Foundation","description":"Information Hub for the LGMD community","publisher":{"@id":"https:\/\/www.lgmd-info.org\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lgmd-info.org\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.lgmd-info.org\/de\/#organization","name":"LGMD Awareness Foundation, Inc.","url":"https:\/\/www.lgmd-info.org\/de\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lgmd-info.org\/de\/#\/schema\/logo\/image\/","url":"https:\/\/lgmd-info.org\/wp-content\/uploads\/2021\/02\/LGMD_Logo.png","contentUrl":"https:\/\/lgmd-info.org\/wp-content\/uploads\/2021\/02\/LGMD_Logo.png","width":208,"height":61,"caption":"LGMD Awareness Foundation, Inc."},"image":{"@id":"https:\/\/www.lgmd-info.org\/de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LGMDawareness\/","https:\/\/x.com\/LgmdAwareness","https:\/\/www.instagram.com\/lgmdawareness\/"]},{"@type":"Person","@id":"https:\/\/www.lgmd-info.org\/de\/#\/schema\/person\/007755074875959ad5503c1c969678c7","name":"dooley","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lgmd-info.org\/de\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c87b3b784fd4c1975884b6c3eab282b5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c87b3b784fd4c1975884b6c3eab282b5?s=96&d=mm&r=g","caption":"dooley"},"sameAs":["https:\/\/live-lgmd-2021.pantheonsite.io"]}]}},"_links":{"self":[{"href":"https:\/\/www.lgmd-info.org\/fr\/wp-json\/wp\/v2\/posts\/1988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lgmd-info.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lgmd-info.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lgmd-info.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lgmd-info.org\/fr\/wp-json\/wp\/v2\/comments?post=1988"}],"version-history":[{"count":0,"href":"https:\/\/www.lgmd-info.org\/fr\/wp-json\/wp\/v2\/posts\/1988\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lgmd-info.org\/fr\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.lgmd-info.org\/fr\/wp-json\/wp\/v2\/media?parent=1988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lgmd-info.org\/fr\/wp-json\/wp\/v2\/categories?post=1988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lgmd-info.org\/fr\/wp-json\/wp\/v2\/tags?post=1988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}